Peritoneal Malignant Mesothelioma — Trials

Peritoneal Malignant Mesothelioma — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06057935	A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma	recruiting	Phase 2	64	Memorial Sloan Kettering Cancer CenterOTHER	1	Sep 24, 2026	clinicaltrials
NCT05001880	Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma	recruiting	Phase 2	66	National Cancer Institute (NCI)NIH	1	Sep 22, 2026	clinicaltrials